Bull case
ABEV would need investors to value it at roughly 23x earnings — about 20x more generous than today's 3x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
Wall Street verdict, consensus price target, and analyst rating breakdown — everything needed to frame the risk/reward at today's price.
Three scenarios for where ABEV stock could go
ABEV would need investors to value it at roughly 23x earnings — about 20x more generous than today's 3x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
At 18x on FY1 earnings, the base case reflects a reasonable but not stretched valuation. It prices in continued growth without assuming an exceptional setup.
The bear case assumes sentiment or fundamentals disappoint enough to push ABEV down roughly 279% from the current price.
Not financial advice. Model confidence reflects internal scenario assumptions, not a guarantee of returns. Past performance does not predict future results.

Ambev is a leading brewer and beverage company that produces, distributes, and sells beer and non-alcoholic drinks across the Americas. It generates revenue primarily from beer sales—which dominate its portfolio—and secondarily from soft drinks, bottled water, and other beverages through its extensive distribution network. The company's competitive advantage lies in its dominant market position in Brazil and Latin America, strong portfolio of local and international brands, and massive scale in production and distribution.
Quarterly beat-or-miss track record against analyst estimates, plus forward revenue and EPS outlook for the next two fiscal years.
| Quarter | EPS (Actual / Est) | EPS Surprise | Revenue (Actual / Est) | Rev Surprise |
|---|---|---|---|---|
| Q3 2025 | $0.03/$0.03 | +0.0% | $3.7B/$4.2B | -11.0% |
| Q4 2025 | $0.04/$0.04 | +0.0% | $3.9B/$4.8B | -18.1% |
| Q1 2026 | $0.05/$0.05 | +0.0% | $5.2B/$4.6B | +13.1% |
| Q2 2026 | $0.05/$0.05 | +0.0% | $4.6B/$4.4B | +4.2% |
ABEV beat EPS estimates in 4 of 4 tracked quarters. A perfect track record raises the bar for the upcoming report.
Current multiples compared to the S&P 500, the company's sector, and its own five-year average.
Fair value est. $17 — implies +456.7% from today's price.
| Metric | ABEV | S&P 500 | Consumer Defensive | 5Y Avg ABEV |
|---|---|---|---|---|
| Forward PE | 2.9x | 18.8x-84% | 14.2x-79% | — |
| Trailing PE | 16.1x | 24.4x-34% | 18.9x-15% | 2.8x+474% |
| PEG Ratio | 2.45x | 1.66x+48% | 1.92x+28% | — |
| EV/EBITDA | 8.1x | 15.2x-47% | 11.1x-27% | 1.0x+710% |
| Price/FCF | 12.6x | 20.7x-39% | 15.3x-18% | 2.3x+439% |
| Price/Sales | 2.8x | 3.1x | 0.9x+221% | 0.5x+472% |
| Dividend Yield | 8.17% | 1.91% | 3.06% | 13.86% |
Forward P/E and PEG reflect analyst consensus estimates. Historical averages use trailing ratios where forward data is unavailable.S&P 500 and sector benchmarks both use trailing median P/E — similar readings indicate the broader index and sector are priced alike.
Open valuation toolABEV generates $22.2B in free cash flow at a 25.1% margin — 22.3% ROIC signals a durable competitive advantage · returns 8.9% of market cap to shareholders annually.
Revenue, margins, and cash generation
ROIC, leverage, and debt serviceability
How capital is returned to owners
All figures from the trailing twelve months. ROIC uses invested capital (equity + net debt).
Open full ratios pageKey factors that could pressure the stock price, compress the multiple, or weigh on future results.
AI analysis · updated June 17, 2026
Ambev's stocks have declined due to heightened concerns about weakening beer demand in key markets.
UBS downgraded Ambev to Sell from Neutral, citing unfavorable risk/reward after a 32% six-month rally.
Following the downgrade, ABEV slipped 2.4%, reflecting negative market sentiment.
Analysts argue the stock's risk/reward no longer justifies its valuation after the recent rally.
Ambev disclosed 49 risk factors in its recent earnings report, indicating broad operational challenges.
These are risk mechanisms, not predictions. The key question is which would force a cut to earnings estimates or a lower multiple than the market currently prices in.
Structural drivers behind the upside case and why the stock could outperform over the next 12 months.
AI analysis · updated June 17, 2026
Ambev S.A. has trailing and forward P/E ratios of 13.45 and 13.26 respectively, indicating a potentially undervalued stock.
The bullish thesis highlights Ambev's strong position in emerging markets, which offers significant growth potential.
Ambev is focusing on premiumization, which could drive higher margins and revenue growth in its product offerings.
Analysts project stable performance and great potential for Ambev in 2026, reinforcing the bullish case.
The number of hedge funds holding ABEV increased from 21 to 23 in the second quarter, signaling growing institutional confidence.
A real bull case compounds — each driver matters most when it strengthens margins, supports capital returns, and keeps the company above the market's minimum growth bar simultaneously.
52-week range context and price returns across multiple time horizons. Dividend contribution is shown separately in the Capital Return section.
Range context matters because valuation compression and earnings misses rarely hit from the same starting point. A stock already far below its high can still fall, but it is no longer carrying the same embedded optimism as one pressing a fresh peak.
Valuation, growth, and margin comparison against the closest publicly traded peers for this company.
| Company | Mkt Cap | Fwd PE | Rev Grw | Margin | Rating | Upside |
|---|---|---|---|---|---|---|
ABE ABEV Ambev S.A. | $48.7B | 2.9x | +6.3% | 17.7% | Hold | +2.6% |
BUD BUD Anheuser-Busch InBev SA/NV | $138.9B | 18.4x | +2.7% | 10.5% | Buy | +10.2% |
TAP TAP Molson Coors Beverage Company | $7.4B | 8.3x | +0.7% | -18.9% | Hold | +19.3% |
SAM SAM The Boston Beer Company, Inc. | $1.9B | 18.5x | +3.4% | -2.9% | Hold | +37.6% |
KO KO The Coca-Cola Company | $341.7B | 24.3x | +2.7% | 27.8% | Buy | +8.5% |
PEP PEP PepsiCo, Inc. | $194.1B | 16.4x | +4.6% | 8.8% | Hold | +18.2% |
This peer comparison reflects companies with similar business models, product lines, or market positioning, supplemented by industry grouping when direct matches are limited.
ABEV returns 8.9% total yield, led by a 8.17% dividend. Buybacks add another 0.8%.
Yield, cadence, and growth quality
How much per-share support comes from repurchases
| Year | Div / Share | YoY Grw | BB Yield | Total Yield |
|---|---|---|---|---|
| 2026 | $0.01 | — | — | — |
| 2025 | $0.20 | +86.6% | 5.0% | 57.8% |
| 2024 | $0.11 | -28.2% | 1.6% | 15.5% |
| 2023 | $0.15 | +4.6% | 0.3% | 27.2% |
| 2022 | $0.14 | +17.6% | 0.1% | 28.5% |
Common questions answered from live analyst data and company financials.
Ambev S.A. (ABEV) is rated Hold by Wall Street analysts as of 2026. Of 14 analysts covering the stock, 2 rate it Buy or Strong Buy, 7 rate it Hold, and 5 rate it Sell or Strong Sell. The consensus 12-month price target is $3, implying +2.6% from the current price of $3. The bear case scenario is $12 and the bull case is $25.
The Wall Street consensus price target for ABEV is $3 based on 14 analyst estimates. The high-end target is $4 (+12.2% from today), and the low-end target is $3 (-7.1%). The base case model target is $19.
ABEV trades at 2.9x times forward earnings. The stock currently trades at a discount to the broader market. Based on current multiples versus the peer group, the relative model signals cheap versus peers. Whether the stock is over or undervalued ultimately depends on whether consensus earnings estimates are achievable.
The primary risks for ABEV in 2026 are: (1) Weakening beer demand — Ambev's stocks have declined due to heightened concerns about weakening beer demand in key markets. (2) Analyst downgrade — UBS downgraded Ambev to Sell from Neutral, citing unfavorable risk/reward after a 32% six-month rally. (3) Market sentiment shift — Following the downgrade, ABEV slipped 2. Each factor has the potential to pressure earnings or compress the stock's valuation multiple.
Analyst consensus estimates ABEV will report consensus revenue of $93.8B (+6.3% year-over-year) and EPS of $1.07 (+7.3% year-over-year) for the upcoming fiscal year. The following year, analysts project $98.4B in revenue.
Ambev S.A. is expected to report its next earnings on approximately 2026-07-30. Consensus expects EPS of $0.04 and revenue of $4.3B. Over recent quarters, ABEV has beaten EPS estimates 42% of the time.
Ambev S.A. (ABEV) generated $22.2B in free cash flow over the trailing twelve months — a free cash flow margin of 25.1%. ABEV returns capital to shareholders through dividends (8.2% yield) and share repurchases ($1.9B TTM).